Webinar

Minimize avoidable amendments and mitigate study risks

Protocol amendments have long been a challenge for the drug development industry given their impact on clinical trial costs and timelines. More than half of finalized protocols undergo an amendment and about half of these are avoidable. Investing in protocol optimization solutions to improve the design process has proven to be essential.

In this webinar, solutions for protocol optimization are shared along with examples demonstrating how IQVIA's data-informed protocol assessment makes an impact on protocol design by reducing risks that could lead to amendments.

Three key take-aways

• Understand the potential impact of protocol amendments on cost and timelines
• See which analytics IQVIA applies when conducting evidence-based protocol reviews
• Discover how "pressure-testing" design decisions with data and analytics optimizes protocols before approval

Speaker

Tammie Nguyen
Design Analytics Director